Loading clinical trials...

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT01508026

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

To evaluate the efficacy and safety of fixed-dose combination of nebivolol and valsartan compared to monotherapy and placebo in patients with stage 1 and stage 2 hypertension.

Lead sponsor: Forest Laboratories•413 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

COMPLETEDPhase 3

Bioactive Milk Peptides and Blood Pressure

NCT01031485 · Stage 1 Hypertension

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 25, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment4,161

Start dateJan 2012

Last updatedApr 25, 2014

Condition

Stage 1 Hypertension Stage 2 Hypertension

Locations shown

Forest Investigative Site 1750

Birmingham, Alabama

Forest Investigative Site 1038

Birmingham, Alabama

Forest Investigative Site 1308

Birmingham, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 25, 2014Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Bioactive Milk Peptides and Blood Pressure

Trial snapshot

Condition

Locations shown

For caregivers